| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| natriumvalproatförgiftning |
Causative agent |
False |
Sodium valproate |
Inferred relationship |
Some |
1 |
| oavsiktlig förgiftning orsakad av natriumvalproat |
Causative agent |
False |
Sodium valproate |
Inferred relationship |
Some |
|
| avsiktlig förgiftning orsakad av natriumvalproat |
Causative agent |
False |
Sodium valproate |
Inferred relationship |
Some |
|
| natriumvalproatförgiftning, med oklar avsikt |
Causative agent |
False |
Sodium valproate |
Inferred relationship |
Some |
1 |
| Sodium valproate adverse reaction |
Causative agent |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
| överdos av natriumvalproat |
Causative agent |
False |
Sodium valproate |
Inferred relationship |
Some |
1 |
| oavsiktlig överdos av natriumvalproat |
Causative agent |
False |
Sodium valproate |
Inferred relationship |
Some |
1 |
| avsiktlig överdos av natriumvalproat |
Causative agent |
False |
Sodium valproate |
Inferred relationship |
Some |
1 |
| överdos av natriumvalproat, med oklar avsikt |
Causative agent |
False |
Sodium valproate |
Inferred relationship |
Some |
1 |
| natriumvalproat 400 mg, pulver och vätska till injektionslösning, flaska |
Has active ingredient |
False |
Sodium valproate |
Inferred relationship |
Some |
|
| natriumvalproat för parenteralt bruk |
Has active ingredient |
False |
Sodium valproate |
Inferred relationship |
Some |
|
| natriumvalproat 500 mg, pulver till injektionsvätska, flaska |
Has active ingredient |
False |
Sodium valproate |
Inferred relationship |
Some |
|
| natriumvalproat 250 mg/5 ml, sirap |
Has active ingredient |
False |
Sodium valproate |
Inferred relationship |
Some |
|
| [X]Valproic acid causing adverse effects in therapeutic use |
Causative agent |
False |
Sodium valproate |
Inferred relationship |
Some |
|
| oavsiktlig förgiftning orsakad av natriumvalproat |
Causative agent |
False |
Sodium valproate |
Inferred relationship |
Some |
1 |
| avsiktlig förgiftning orsakad av natriumvalproat |
Causative agent |
False |
Sodium valproate |
Inferred relationship |
Some |
1 |
| natriumvalproat för oralt bruk, tablett med modifierad frisättning |
Has active ingredient |
False |
Sodium valproate |
Inferred relationship |
Some |
|
| natriumvalproat 100 mg, krossbar tablett |
Has active ingredient |
False |
Sodium valproate |
Inferred relationship |
Some |
|
| natriumvalproat 200 mg/5 ml, sirap |
Has active ingredient |
False |
Sodium valproate |
Inferred relationship |
Some |
|
| natriumvalproat 300 mg, tablett med modifierad frisättning |
Has active ingredient |
False |
Sodium valproate |
Inferred relationship |
Some |
|
| natriumvalproat 500 mg, tablett med modifierad frisättning |
Has active ingredient |
False |
Sodium valproate |
Inferred relationship |
Some |
|
| natriumvalproat för oralt bruk |
Has active ingredient |
False |
Sodium valproate |
Inferred relationship |
Some |
|
| natriumvalproat 200 mg, tablett med modifierad frisättning |
Has active ingredient |
False |
Sodium valproate |
Inferred relationship |
Some |
|
| natriumvalproat 200 mg/5 ml, sockerfri lösning för oralt bruk |
Has active ingredient |
False |
Sodium valproate |
Inferred relationship |
Some |
|
| Sodium valproate 200 mg gastro-resistant oral tablet |
Has active ingredient |
False |
Sodium valproate |
Inferred relationship |
Some |
|
| Sodium valproate 500 mg gastro-resistant oral tablet |
Has active ingredient |
False |
Sodium valproate |
Inferred relationship |
Some |
|
| Sodium valproate blood measurement |
Component |
True |
Sodium valproate |
Inferred relationship |
Some |
2 |
| Serum sodium valproate measurement |
Component |
True |
Sodium valproate |
Inferred relationship |
Some |
2 |
| natriumvalproat 100 mg/ml, injektionsvätska, lösning |
Has active ingredient |
False |
Sodium valproate |
Inferred relationship |
Some |
|
| natriumvalproatallergi |
Causative agent |
False |
Sodium valproate |
Inferred relationship |
Some |
2 |
| natriumvalproat 100 mg, tablett |
Has active ingredient |
False |
Sodium valproate |
Inferred relationship |
Some |
|
| Sodium valproate 300 mg prolonged-release oral tablet |
Has basis of strength substance (attribute) |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
| Sodium valproate 300 mg prolonged-release oral tablet |
Has precise active ingredient |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
| Sodium valproate 200 mg gastro-resistant oral tablet |
Has precise active ingredient |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
| Sodium valproate 200 mg gastro-resistant oral tablet |
Has basis of strength substance (attribute) |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
| Sodium valproate 500 mg gastro-resistant oral tablet |
Has basis of strength substance (attribute) |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
| Sodium valproate 500 mg gastro-resistant oral tablet |
Has precise active ingredient |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
| Sodium valproate 500 mg prolonged-release oral tablet |
Has basis of strength substance (attribute) |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
| Sodium valproate 500 mg prolonged-release oral tablet |
Has precise active ingredient |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
| Sodium valproate 200 mg prolonged-release oral tablet |
Has precise active ingredient |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
| Sodium valproate 200 mg prolonged-release oral tablet |
Has basis of strength substance (attribute) |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
| Sodium valproate 400 mg powder for solution for injection vial |
Has precise active ingredient |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
| Sodium valproate 400 mg powder for solution for injection vial |
Has basis of strength substance (attribute) |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
| Sodium valproate 40 mg/mL oral solution |
Has basis of strength substance (attribute) |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
| Sodium valproate 40 mg/mL oral solution |
Has precise active ingredient |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
| natriumvalproatallergi |
Causative agent |
False |
Sodium valproate |
Inferred relationship |
Some |
1 |
| Sodium valproate 100 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
| Sodium valproate 100 mg oral tablet |
Has precise active ingredient |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
| Sodium valproate 100 mg/mL solution for injection |
Has precise active ingredient |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
| Sodium valproate 100 mg/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Sodium valproate |
Inferred relationship |
Some |
1 |
| Sodium valproate 133 mg and valproic acid 58 mg prolonged-release oral tablet |
Has precise active ingredient |
True |
Sodium valproate |
Inferred relationship |
Some |
2 |
| Sodium valproate 133 mg and valproic acid 58 mg prolonged-release oral tablet |
Has basis of strength substance (attribute) |
True |
Sodium valproate |
Inferred relationship |
Some |
2 |
| Sodium valproate 333 mg and valproic acid 145 mg prolonged-release oral tablet |
Has precise active ingredient |
True |
Sodium valproate |
Inferred relationship |
Some |
2 |
| Sodium valproate 333 mg and valproic acid 145 mg prolonged-release oral tablet |
Has basis of strength substance (attribute) |
True |
Sodium valproate |
Inferred relationship |
Some |
2 |
| Sodium valproate 200 mg and valproic acid 87 mg prolonged-release oral tablet |
Has precise active ingredient |
True |
Sodium valproate |
Inferred relationship |
Some |
2 |
| Sodium valproate 200 mg and valproic acid 87 mg prolonged-release oral tablet |
Has basis of strength substance (attribute) |
True |
Sodium valproate |
Inferred relationship |
Some |
2 |
| Sodium valproate 66.66 mg and valproic acid 29.03 mg prolonged-release oral granules sachet |
Has precise active ingredient |
True |
Sodium valproate |
Inferred relationship |
Some |
2 |
| Sodium valproate 66.66 mg and valproic acid 29.03 mg prolonged-release oral granules sachet |
Has basis of strength substance (attribute) |
True |
Sodium valproate |
Inferred relationship |
Some |
2 |
| Product containing precisely sodium valproate 166.76 milligram and valproic acid 72.61 milligram/1 sachet prolonged-release oral granules (clinical drug) |
Has precise active ingredient |
True |
Sodium valproate |
Inferred relationship |
Some |
2 |
| Product containing precisely sodium valproate 166.76 milligram and valproic acid 72.61 milligram/1 sachet prolonged-release oral granules (clinical drug) |
Has basis of strength substance (attribute) |
True |
Sodium valproate |
Inferred relationship |
Some |
2 |
| Sodium valproate 333.3 mg and valproic acid 145.14 mg prolonged-release oral granules sachet |
Has precise active ingredient |
True |
Sodium valproate |
Inferred relationship |
Some |
2 |
| Sodium valproate 333.3 mg and valproic acid 145.14 mg prolonged-release oral granules sachet |
Has basis of strength substance (attribute) |
True |
Sodium valproate |
Inferred relationship |
Some |
2 |